IL1B and gout: Although IL-1β neutralization was once thought to be predominantly limited to the treatment of autoimmune and chronic inflammatory diseases, including gout, rheumatoid arthritis or type 2 diabetes, the role of IL-1β in cardiovascular diseases has gained more and more in importance.31